![](https://i0.wp.com/bioengineer.org/wp-content/uploads/2024/07/Meet-Insilico-in-Singapore-Alex-Zhavoronkov-PhD-shares-insights-into.jpeg?fit=700%2C394&ssl=1)
Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery
From July 30-31, Alex Zhavoronkov, PhD, founder and co-CEO of clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine will be attending SCRI Clinical Trials Symposium 2024 at Raffles City Convention Centre, and …